95.03
0.21 (0.22%)
Penutupan Terdahulu | 94.82 |
Buka | 94.30 |
Jumlah Dagangan | 537,019 |
Purata Dagangan (3B) | 744,580 |
Modal Pasaran | 5,616,225,280 |
Harga / Pendapatan (P/E TTM) | 46.58 |
Harga / Pendapatan (P/E Ke hadapan) | 29.50 |
Harga / Jualan (P/S) | 4.14 |
Harga / Buku (P/B) | 3.96 |
Julat 52 Minggu | |
Tarikh Pendapatan | 30 Jul 2025 - 4 Aug 2025 |
Margin Keuntungan | 8.81% |
Margin Operasi (TTM) | 11.83% |
EPS Cair (TTM) | 2.04 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 9.80% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | 6.80% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 57.24% |
Nisbah Semasa (MRQ) | 4.87 |
Aliran Tunai Operasi (OCF TTM) | 225.16 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 172.75 M |
Pulangan Atas Aset (ROA TTM) | 4.32% |
Pulangan Atas Ekuiti (ROE TTM) | 9.16% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
Medical Instruments & Supplies (Global) | Menurun | Menurun | |
Stok | Merit Medical Systems, Inc. | Menurun | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 2.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 2.0 |
Purata Bergerak Teknikal | 3.5 |
Osilator Teknikal | -3.5 |
Purata | 1.00 |
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices. |
|
Sektor | Healthcare |
Industri | Medical Instruments & Supplies |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 2.26% |
% Dimiliki oleh Institusi | 105.00% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 120.00 (JP Morgan, 26.28%) | Beli |
Median | 109.00 (14.70%) | |
Rendah | 103.00 (Barrington Research, 8.39%) | Beli |
Purata | 109.88 (15.63%) | |
Jumlah | 8 Beli | |
Harga Purata @ Panggilan | 96.87 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Piper Sandler | 23 May 2025 | 110.00 (15.75%) | Beli | 95.38 |
23 Apr 2025 | 112.00 (17.86%) | Beli | 93.76 | |
Canaccord Genuity | 21 May 2025 | 112.00 (17.86%) | Beli | 96.49 |
25 Apr 2025 | 108.00 (13.65%) | Beli | 94.61 | |
Wells Fargo | 21 May 2025 | 108.00 (13.65%) | Beli | 96.49 |
Needham | 20 May 2025 | 108.00 (13.65%) | Beli | 98.81 |
15 May 2025 | 108.00 (13.65%) | Beli | 97.57 | |
Baird | 25 Apr 2025 | 110.00 (15.75%) | Beli | 94.61 |
Barrington Research | 25 Apr 2025 | 103.00 (8.39%) | Beli | 94.61 |
11 Apr 2025 | 111.00 (16.81%) | Beli | 92.04 | |
Raymond James | 25 Apr 2025 | 108.00 (13.65%) | Beli | 94.61 |
JP Morgan | 28 Mar 2025 | 120.00 (26.28%) | Beli | 103.94 |
Papar semua |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |